A detailed history of Wedge Capital Management L L P transactions in Eli Lilly & CO stock. As of the latest transaction made, Wedge Capital Management L L P holds 876 shares of LLY stock, worth $697,006. This represents 0.01% of its overall portfolio holdings.

Number of Shares
876
Previous 847 3.42%
Holding current value
$697,006
Previous $766,000 1.31%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$772.14 - $960.02 $22,392 - $27,840
29 Added 3.42%
876 $776,000
Q2 2024

Jul 17, 2024

SELL
$724.87 - $909.04 $2,174 - $2,727
-3 Reduced 0.35%
847 $766,000
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $49,152 - $65,759
83 Added 10.82%
850 $661,000
Q4 2023

Feb 01, 2024

SELL
$525.19 - $619.13 $13,654 - $16,097
-26 Reduced 3.28%
767 $447,000
Q3 2023

Oct 13, 2023

SELL
$434.7 - $599.3 $283,424 - $390,743
-652 Reduced 45.12%
793 $425,000
Q2 2023

Jul 17, 2023

SELL
$350.74 - $468.98 $12,626 - $16,883
-36 Reduced 2.43%
1,445 $677,000
Q1 2023

Apr 11, 2023

SELL
$310.63 - $364.82 $1,242 - $1,459
-4 Reduced 0.27%
1,481 $508,000
Q4 2022

Jan 17, 2023

BUY
$321.55 - $374.67 $9,003 - $10,490
28 Added 1.92%
1,485 $543,000
Q3 2022

Oct 13, 2022

SELL
$296.48 - $337.87 $18,085 - $20,610
-61 Reduced 4.02%
1,457 $471,000
Q1 2022

Apr 12, 2022

SELL
$234.69 - $291.66 $16,897 - $20,999
-72 Reduced 4.53%
1,518 $435,000
Q3 2021

Oct 14, 2021

SELL
$221.6 - $272.71 $3,767 - $4,636
-17 Reduced 1.06%
1,590 $367,000
Q2 2021

Jul 14, 2021

SELL
$180.55 - $233.54 $59,942 - $77,535
-332 Reduced 17.12%
1,607 $369,000
Q1 2021

Apr 12, 2021

SELL
$164.32 - $212.72 $46,831 - $60,625
-285 Reduced 12.81%
1,939 $362,000
Q4 2020

Jan 08, 2021

BUY
$130.46 - $172.63 $12,002 - $15,881
92 Added 4.32%
2,224 $376,000
Q3 2020

Oct 08, 2020

BUY
$146.22 - $169.13 $19,447 - $22,494
133 Added 6.65%
2,132 $316,000
Q2 2020

Jul 10, 2020

SELL
$136.42 - $164.18 $4,229 - $5,089
-31 Reduced 1.53%
1,999 $328,000
Q1 2020

Apr 13, 2020

SELL
$119.05 - $147.35 $8,690 - $10,756
-73 Reduced 3.47%
2,030 $282,000
Q4 2019

Jan 15, 2020

BUY
$106.92 - $132.43 $1,389 - $1,721
13 Added 0.62%
2,103 $276,000
Q3 2019

Nov 01, 2019

BUY
$106.79 - $116.16 $7,261 - $7,898
68 Added 3.36%
2,090 $234,000
Q2 2019

Aug 01, 2019

BUY
$110.79 - $129.32 $224,017 - $261,485
2,022 New
2,022 $224,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wedge Capital Management L L P Portfolio

Follow Wedge Capital Management L L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

News

Stay updated on Wedge Capital Management L L P with notifications on news.